BASEL, Switzerland
,
February 2, 2022
(press release)
–
Today Bayer announced Dr. Ricardo Salazar Hernández as the new Chief Medical Officer of the Consumer Health division starting May 1st. In his new role, Dr. Salazar will lead the Global Medical Affairs function with responsibilities over medical insights, claims and evidence strategies and generation, and health care professional engagement. “From product safety and effectiveness, to helping create entirely new solutions based on medical insights, credible science has always been at the heart of science-led self-care at Bayer,” said Abbie Lennox, Chief Regulatory, Medical, Safety and product Compliance officer at Consumer Health. “The extensive public and private sector medical experience Ricardo brings to bear will help us continue to shape the transformation of everyday health for consumers.” Dr. Salazar was born and educated in Mexico and he has more than 15 years of experience in the pharmaceutical industry. He joins Bayer from Sanofi where he most recently was global medical Head for Consumer Health Care (CHC) & Evidence generation head. He is a trained MD with a master’s degree in health business administration. He also completed post graduate studies in pharmaceutical medicine at the University of Cardiff, UK. Prior to his current role, he has held various roles of increasing responsibility in Mexico, Brazil, France and Panama in medical affairs and business development. “I am really happy to join and be part of the Bayer team, looking forward to help continue to building a stronger, high-performing medical organization that is able to deliver new medical insights, scientific claims and new data generation,” said Dr. Salazar. “We will work together to help consumers and healthcare professionals to make informed decisions about our exciting product portfolio.” Earlier in his career, Dr. Salazar worked as an Advisor at the Ministry of Health in Mexico, an Associate Professor at ITESM CDM Medical School in Mexico and in private medical practice at Hospital Médica Sur in Mexico City. Ricardo and his wife Gaby have two children, Mateo and Mikel. The Salazar family will relocate from Panama to Whippany, New Jersey. About Bayer Forward-Looking Statements
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros. For more information, go to www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
